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An epidemic of leukemia among bivalve molluscs is spreading along the Atlantic coast of North
America, with a serious population decline of soft-shelled clams. In this issue of Cell, Metzger
et al. use forensic DNA markers to demonstrate that the leukemia cells have a clonal origin and
appear to be transmitted through sea water.Those of uswho have enjoyed clam bakes
on the beach at Cold Spring Harbor Lab-
oratory may soon find that this mode
of networking among scientists has
become a thing of the past. The soft-
shelled clam (Mya arenaria) is suffering a
population dive owing to the spread of a
lethal leukemia-like cell. Similar leukemias
have been observed in other species of
edible bivalve molluscs such as mussels,
cockles, and oysters that are farmed
along the Atlantic littoral of North America.
The disease in soft-shelled clams now
ranges from Chesapeake Bay to the
Canadian province of Prince Edward
Island 1,500 km to the northeast. Importa-
tion of clam stocks by shellfish farmers
may have exacerbated its spread.
Steve Goff’s laboratory at Columbia
University, working with ecologists at
Environment Canada, had previously
identified a retrotransposon in the clams
called Steamer, which is greatly amplified
in the leukemic cells (Arriagada et al.,
2014). Using genetic analysis of Steamer
integration sites, mitochondrial single-
nucleotide polymorphisms, andmicrosat-
ellite variation, they now show that the
leukemia has a monoclonal origin sharing
common alleles that are different from
their hosts (Metzger et al., 2015). In this
respect, the leukemia in clams is similar
to the Devil facial tumor disease (DFTD)
of the marsupial carnivore, the Tasmanian
devil, whose survival is endangered by
rapidly spreading infection of a clonal
neuro-endocrine cancer (Pearse and
Swift, 2006, Murchison et al., 2012), and
to canine transmissible venereal tumor
(CTVT), which has a worldwide distribu-
tion in dogs (Murgia et al., 2006; Murchi-
son et al., 2014).
DFTD is spread by biting, whereas
CTVT, as its name implies, is sexuallytransmitted. The mode of transmission
of the clam leukemia is not yet firmly
established, but it is likely that these filter
feeders take up tumor cells from the
seawater through their siphons (Figure 1)
and that the cells then parasitize the new
host. When the leukemic clone of clams
first emerged is unknown, but since the
disease was noted in the late 1970s, it
must be at last 40 years old. DFTD was
first recorded in Tasmanian devils in
1996 (Pearse and Swift 2006), whereas
the venereal tumor in dogs is estimated
to date from an ancient breed like the
husky some 11,000 years ago (Murchison
et al., 2014). Of course, even a 10,000
year period is a snapshot on the evolu-
tionary timescale of the hosts, and one
can speculate how many other cases of
tumor cells evolving into parasites may
have occurred in species that may now
be extinct.
In addition to the three naturally occur-
ring transmissible tumors of clams, dogs,
and devils, there are several case his-
tories of human malignancy arising from
occult tumor cells in donor organ or tissue
transplants that then emerge in the immu-
nosuppressed transplant recipient (Mur-
gia et al., 2006; Siddle and Kaufman,
2015). There are also cases of transpla-
cental tumor transmission from mother
to child and between twins in utero.
Among inbred strains of laboratory
rodents, there would be an opportunity
for tumor cells to spread from one individ-
ual to another without crossing a major
histocompatibility (MHC) barrier. How-
ever, only one example has been docu-
mented—that of leukemia in a colony of
Syrian hamsters at NIH 50 years ago; the
leukemic cells could even be transmitted
by mosquitoes (Banfield et al., 1965), pre-
sumably by passive transfer on the mouthCelparts rather than by undergoing a replica-
tion cycle in the insect host.
How do transmissible tumors manage
to overcome histocompatibility barriers?
It appears that there are a variety of mech-
anisms, including downregulation of class
I and class II MHC genes and secretion
of immunosuppressive cytokines (Belov,
2012; Siddle and Kaufman, 2015). In
CTVT, there is a fine balance between
progressive disease without an anti-
tumor immune response and regression
when allograft rejection kicks in. In
DTFD, the tumor is relentlessly progres-
sive. Both CTVT and DFTD have close to
homozygous MHC class I alleles, and
their initial emergence may have been
facilitated by a relatively inbred host
population with limited MHC diversity.
Invertebrates like clams do not have
as sophisticated a tissue recognition
system as the MHC of higher vertebrates,
yet certain cell surface molecules help
to distinguish between self and non-
self. However, non-malignant somatic
cell invasion and even germ cell para-
sitism has been documented in marine in-
vertebrates such as colonial tunicates
(Rinkevich, 2011). Metzger et al. (2015)
suggest that the lack of an MHC system
may make molluscs more susceptible
than vertebrates to transmissible tumors.
As CTVT is the only known transmissible
cancer that can regress, understanding
what triggers rejection may be key to
inducing regression of other transmissible
tumors and perhaps non-transmissible
cancers too.
As Metzger et al. (2015) document in
their Introduction, leukemia occurs not
only in soft-shelled clams, but also
in other bivalve molluscs in the same
region of North America. This observa-
tion raises the question of whether thel 161, April 9, 2015 ª2015 Elsevier Inc. 191
Figure 1. A Bowl of Soft-Shelled Clams, Mya arenaria, with Extended Siphons
Courtesy of the Department for Natural Resources, State of Maryland.tumors in other species represent cross-
species infections from Mya arenaria or
whether each host species has evolved
its own transmissible tumor. CTVT is
known to be readily transplantable
experimentally to other canid species
and even to foxes (Murgia et al., 2006;
Belov, 2012), and it will be easy to deter-
mine the species of origin of transmis-
sible leukemias in other bivalves. If
each tumor is species specific, what
environmental factors may have facili-192 Cell 161, April 9, 2015 ª2015 Elsevier Inctated their independent emergence
around the same time and place?
How might transmissible tumors be
contained to reduce the threat to their
host species? CTVT in dogs has spread
to all five continents, but it is self-limiting
and presents no danger to the host spe-
cies as a whole. In India, the high inci-
dence of CTVT in street dogs has been
diminished in some cities by castration.
To save the Tasmanian devil from extinc-
tion, a possible tumor vaccine is being.explored as well as containment of
healthy animals on islands and on penin-
sulas with barrier fences to keep out
affected devils (Belov, 2012). For the
soft-shelled clam, it will be important to
be vigilant to stop importation of clams
from affected areas to currently unaf-
fected ones like Florida.
In the meantime, it is safe for humans to
eat clams, even raw oysters. Enjoy them
while you can!REFERENCES
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